HemaCare provides a variety of quality, controlled, consistent, viable human primary cells and blood components derived from an assortment of tissues. Our cell processing lab is capable of purifying lymphocytes, monocytes, neutrophils, CD34⁺ stem cells, and much more!

View our BioResearch Products Catalog

Tissues

• Peripheral Blood

• Mobilized Peripheral Blood

• Bone Marrow (coming soon)

• Cord Blood (coming soon)

Cell/Fluid Type

• Buffy Coat
• CD3⁺ Pan T Cells
• CD4⁺ Helper T Cells
• CD4⁺/CD25⁺ Regulatory T Cells
• CD8⁺ Cytotoxic T Cells
• CD14⁺ Monocytes
• CD19⁺ B Cells
• CD133⁺
• CD34⁺ Stem/Progenitor Cells
• CD34 Depleted Stem/Progenitor Cells
• CD56⁺ NK Cells
• Dendritic Cells
• Leukopak
• Mononuclear Cells
• Neutrophils
• Plasma
• Platelets
• Serum
• Whole Blood

Quality of living cellular raw material is a major determinant of final product characteristics. Controlling and qualifying the cell collection step is essential to minimizing operational sources of variability, and greatly increases the likelihood of success in manufacturing. HemaCare’s specialty is apheresis collection, and, building on over 35 years of experience, has addressed this need for optimized cell collection with a program for controlling and qualifying its apheresis procedures and collection sites, bringing a higher degree of reproducibility to research projects or manufacturing efforts based on cGMP and cGTP principles.

Optimizing Apheresis Cellular Collections
Click here to view the presentation